Ellence Solution For Injection 2Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Ellence: Solution for injection (2mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

EPIRUBICIN (ep i ROO bi sin) is a chemotherapy drug. This medicine is used to treat breast cancer.

In-Depth Information
Select a Medication

Ellence 200mg/100ml Solution for Injection

NDC: 000095093
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Breast Cancer

Sometimes used for but not FDA approved for the following conditions:
Multiple Myeloma, Gastric Cancer, Hepatocellular Cancer, Ovarian Cancer, Soft-tissue Sarcoma, Peripheral Blood Stem Cell (PBSC) Mobilization, Bladder Cancer

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Protect from freezing
Ellence 200mg/100ml Solution for Injection

Reported Side Effects for Ellence 200mg/100ml Solution for Injection

Mouth Ulcers Incidence:
<8.9%*
Severity: SEVERE
Onset: DELAYED
Secondary Malignancy Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Heart Failure Incidence:
<15.0%*
Severity: SEVERE
Onset: DELAYED
Throat Inflammation Incidence:
<8.9%*
Severity: SEVERE
Onset: DELAYED
Itching Incidence:
0.3%*
Severity: SEVERE
Onset: RAPID
Skin Rash Incidence:
0.3%*
Severity: SEVERE
Onset: EARLY
Injection Site Reaction Incidence:
0.3%*
Severity: SEVERE
Onset: RAPID
Loose Stools Incidence:
0.8%*
Severity: SEVERE
Onset: EARLY
Infection Incidence:
1.6%*
Severity: SEVERE
Onset: DELAYED
Tiredness Incidence:
1.9%*
Severity: SEVERE
Onset: EARLY
Decreased Appetite Incidence:
2.9%*
Severity: MILD
Onset: DELAYED
Hot Flashes Incidence:
4.0%*
Severity: SEVERE
Onset: EARLY
Fever Incidence:
5.2%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
5.4%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
5.8%*
Severity: SEVERE
Onset: DELAYED
Conjunctivitis Incidence:
14.8%*
Severity: MODERATE
Onset: DELAYED
Eye Inflammatoin Incidence:
14.8%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
25.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
25.0%*
Severity: SEVERE
Onset: EARLY
Hair Loss Incidence:
56.6%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
58.6%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cells Incidence:
67.2%*
Severity: SEVERE
Onset: DELAYED
No Menstrual Periods Incidence:
71.8%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Ellence

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5